SCHEMBL10198481

SCHEMBL10198481

CCN(C)S(=O)(=O)C(F)(F)F

nearest known ligand 0.30

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CA7 P43166 1/20 0.30
CA13 Q8N1Q1 1/20 0.30
EPHX1 P07099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10195803 0.80 CA1 (0.39) CA1CA2EPHX1
SCHEMBL10061729 0.77 EPHX1 (0.38) CA1EPHX1
SCHEMBL10180979 0.76 LMNA (0.33) CA1CA2CA7CA13EPHX1
SCHEMBL13849295 0.76
SCHEMBL2204176 0.76 CA1 (0.32) CA1CA2CA7CA13EPHX1
SCHEMBL19996146 0.75
SCHEMBL14422905 0.75 CA2 (0.39) CA1CA2
SCHEMBL31026913 0.73 CA2 (0.42) CA1CA2
SCHEMBL7069121 0.72
SCHEMBL25632255 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024198675-A1 SODIUM-ION BATTERY ELECTROLYTE AND SODIUM-ION BATTERY 杭州菲科技术创新有限公司 2024-10-03 WO claimed
CN-121839874-A Nonaqueous electrolyte of lithium ion battery and lithium ion battery 远景动力技术(江苏)有限公司 2026-04-10 CN disclosed
WO-2025129749-A1 NEGATIVE ELECTRODE SHEET, BATTERY, PREPARATION METHOD, AND USE 惠州锂威新能源科技有限公司 2025-06-26 WO disclosed
WO-2024198675-A1 SODIUM-ION BATTERY ELECTROLYTE AND SODIUM-ION BATTERY 杭州菲科技术创新有限公司 2024-10-03 WO disclosed
CN-117410568-B Wide-temperature-range high-voltage lithium battery electrolyte and preparation method thereof 华南师范大学 2024-05-31 CN disclosed
CN-117410568-A Wide-temperature-range high-voltage lithium battery electrolyte and preparation method thereof 华南师范大学 2024-01-16 CN disclosed
US-20230159569-A1 DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF UNIVERSITY OF MARYLAND, BALTIMORE (US) 2023-05-25 US disclosed
US-20120115819-A1 Pentacycline Compounds TETRAPHASE PHARMACEUTICALS, INC. 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159569-A1 DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF HDAC6, PSMG3, PSMB2 CA1 2163/4885CA2 3553/4885CA7 3736/4885
US-20120115819-A1 Pentacycline Compounds TSLP, IL5, IL17A CA1 1430/4885CA2 651/4885CA7 1255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.